Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Zuberbier

Showing results (381-390 of 423) with videos related to

Pageof 43
Sort By:
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Clinical and Translational Allergy|November 29, 2024
10 practical priorities to prevent and manage serious allergic reactions: GA<sup>2</sup>LEN ANACare and EFA Anaphylaxis ManifestoAntonella Muraro, Debra de Silva, Marcia Podesta, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2012
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminarJosep M Antó, Mariona Pinart, Mübeccel Akdis, et al.
The World Allergy Organization Journal|June 15, 2026
Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE studyIvan Cherrez-Ojeda, Karla Robles-Velasco, Ana Giménez-Arnau, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 11, 2024
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical PracticeIvan Cherrez-Ojeda, Jean Bousquet, Ana Giménez-Arnau, et al.
The Lancet. Digital Health|March 5, 2023
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data studyBernardo Sousa-Pinto, Cristina Jácome, Ana Margarida Pereira, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Journal of Thoracic Disease|September 28, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Pageof 43

Showing results (381-390 of 423) with videos related to

Sort By:
Pageof 43
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Clinical and Translational Allergy|November 29, 2024
10 practical priorities to prevent and manage serious allergic reactions: GA<sup>2</sup>LEN ANACare and EFA Anaphylaxis ManifestoAntonella Muraro, Debra de Silva, Marcia Podesta, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2012
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminarJosep M Antó, Mariona Pinart, Mübeccel Akdis, et al.
The World Allergy Organization Journal|June 15, 2026
Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE studyIvan Cherrez-Ojeda, Karla Robles-Velasco, Ana Giménez-Arnau, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 11, 2024
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical PracticeIvan Cherrez-Ojeda, Jean Bousquet, Ana Giménez-Arnau, et al.
The Lancet. Digital Health|March 5, 2023
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data studyBernardo Sousa-Pinto, Cristina Jácome, Ana Margarida Pereira, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Journal of Thoracic Disease|September 28, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Pageof 43